DRAM2 (DNA damage-regulated autophagy modulator protein 2) is a 266 amino acid lysosomal membrane protein with six predicted transmembrane helices, belonging to the DRAM/TMEM150 family. DRAM2 functions as a regulator/adaptor in endolysosomal trafficking and autophagic flux rather than as an enzyme. It localizes to lysosomal membranes where it co-localizes with LAMP1/2, clathrin, and adaptor protein complexes AP-1/AP-3. Loss of DRAM2 function results in impaired LC3 lipidation, reduced lysosomal hydrolase activity (cathepsin D, GBA, PPT1), and sphingolipid accumulation. Biallelic mutations in DRAM2 cause cone-rod dystrophy 21 (CORD21), an autosomal recessive retinal dystrophy with early macular involvement. In the retina, DRAM2 localizes to photoreceptor inner segments and the apical surface of retinal pigment epithelial cells, where it is essential for photoreceptor renewal and recycling.
| GO Term | Evidence | Action | Reason |
|---|---|---|---|
| GO:0005764 lysosome | IBA GO_REF:0000033 | ACCEPT | Summary: Phylogenetically inferred lysosomal localization is strongly supported by experimental evidence. DRAM2 has been directly shown to localize to lysosomes by immunofluorescence in multiple studies [PMID:19556885, PMID:19895784]. Recent patient-derived iPSC studies confirm DRAM2 enrichment on lysosomal membranes with co-localization to LAMP2+ compartments [Tsikandelova 2024]. Reason: IBA annotation is consistent with direct experimental evidence from multiple independent studies demonstrating lysosomal localization by immunofluorescence and co-localization with lysosomal markers LAMP1/2. Supporting Evidence: PMID:19556885 DRAM2 is also a lysosomal protein PMID:19895784 DRAM2 is mainly localized in the lysosome, and co-localizes with DRAM file:human/DRAM2/DRAM2-deep-research-falcon.md DRAM2 shows punctate vesicular localization enriched on lysosomal membranes in human retinal organoids; it nests within/adjacent to LAMP2+ compartments |
| GO:0010506 regulation of autophagy | IBA GO_REF:0000033 | ACCEPT | Summary: Phylogenetically inferred role in autophagy regulation is consistent with the protein family's function. DRAM2 belongs to the DRAM/TMEM150 family characterized by autophagy modulation. Experimental evidence demonstrates DRAM2 involvement in autophagic flux: patient-derived cells show impaired LC3 lipidation responses [Tsikandelova 2024]. DRAM2 loss causes defects in autophagy initiation/maturation affecting the BECN1/RUBCN axis. Reason: Core function of DRAM2 supported by family membership and experimental evidence showing impaired autophagic flux (LC3 lipidation defects) in DRAM2-deficient human retinal cells. Supporting Evidence: PMID:19895784 Damage-regulated autophagy regulator (DRAM) has been identified as an effector molecule that is critical for p53-mediated apoptosis, and we investigated whether there might be other DRAM-like molecules linking autophagy and apoptosis file:human/DRAM2/DRAM2-deep-research-falcon.md DRAM2 deficiency led to impaired autophagic flux (blunted LC3-II changes with bafilomycin/rapamycin) |
| GO:0045494 photoreceptor cell maintenance | IBA GO_REF:0000033 | ACCEPT | Summary: Phylogenetically inferred role in photoreceptor maintenance is strongly supported by human genetic and functional data. Biallelic mutations in DRAM2 cause cone-rod dystrophy 21 (CORD21) characterized by photoreceptor degeneration [PMID:25983245]. DRAM2 localizes to photoreceptor inner segments and is involved in photoreceptor renewal and recycling. Patient-derived iPSC retinal organoids show photoreceptor dysfunction [Tsikandelova 2024]. Reason: Core function in retinal biology. Human genetic evidence demonstrates that DRAM2 loss causes photoreceptor degeneration (CORD21). Mouse models confirm age-related photoreceptor degeneration with Dram2 loss. Supporting Evidence: PMID:25983245 DRAM2 encodes a transmembrane lysosomal protein thought to play a role in the initiation of autophagy. Immunohistochemical analysis showed DRAM2 localization to photoreceptor inner segments and to the apical surface of retinal pigment epithelial cells where it might be involved in the process of photoreceptor renewal and recycling to preserve visual function. file:human/DRAM2/DRAM2-deep-research-falcon.md Biallelic DRAM2 (TMEM77) causes autosomal-recessive cone-rod dystrophy (CORD21) |
| GO:0001917 photoreceptor inner segment | IEA GO_REF:0000120 | ACCEPT | Summary: Computational annotation of photoreceptor inner segment localization is supported by immunohistochemical evidence in human and mouse retina. PMID:25983245 directly demonstrated DRAM2 localization to photoreceptor inner segments by immunohistochemistry. Reason: IEA annotation is correct and supported by direct experimental evidence from immunohistochemistry showing DRAM2 in photoreceptor inner segments. Supporting Evidence: PMID:25983245 Immunohistochemical analysis showed DRAM2 localization to photoreceptor inner segments |
| GO:0005765 lysosomal membrane | IEA GO_REF:0000044 | ACCEPT | Summary: UniProt subcellular location-based annotation of lysosomal membrane localization is accurate. DRAM2 is a six-pass transmembrane protein confirmed to reside in lysosomal membranes by immunofluorescence [PMID:19556885, PMID:19895784] and co-localization with lysosomal markers LAMP1/2 [Tsikandelova 2024]. Reason: Accurate IEA annotation consistent with the protein's documented localization as a multi-pass lysosomal membrane protein. Supporting Evidence: PMID:19556885 DRAM2 is also a lysosomal protein PMID:19895784 DRAM2 is mainly localized in the lysosome |
| GO:0006914 autophagy | IEA GO_REF:0000043 | ACCEPT | Summary: UniProt keyword-based annotation of autophagy involvement is appropriate. DRAM2 regulates autophagic flux as demonstrated by impaired LC3 lipidation in DRAM2-deficient cells. The protein name itself (DNA damage-regulated autophagy modulator protein 2) reflects this core function. However, this is a parent term of 'regulation of autophagy' (GO:0010506) which is also annotated with experimental evidence. Reason: Accurate IEA annotation. DRAM2 is legitimately involved in autophagy as part of its core function regulating autophagic flux. This broader term complements the more specific 'regulation of autophagy' annotation. Supporting Evidence: PMID:19895784 Damage-regulated autophagy regulator (DRAM) has been identified as an effector molecule that is critical for p53-mediated apoptosis, and we investigated whether there might be other DRAM-like molecules linking autophagy and apoptosis |
| GO:0006915 apoptotic process | IEA GO_REF:0000043 | KEEP AS NON CORE | Summary: UniProt keyword-based annotation derives from experimental work showing DRAM2 co-expression with DRAM1 induces apoptosis [PMID:19895784]. However, DRAM2 alone does not induce cell death; the apoptotic effect requires DRAM1 co-expression. This appears to be a secondary effect rather than a direct function. Reason: DRAM2 alone does not induce apoptosis. The apoptotic effect requires DRAM1 co-expression, suggesting this is an indirect effect mediated through autophagy-apoptosis crosstalk rather than a direct DRAM2 function. Keeping as non-core to reflect this indirect relationship. Supporting Evidence: PMID:19895784 While expression of DRAM or DRAM2 individually did not induce cell death, co-expression of DRAM2 with DRAM significantly induced cell death |
| GO:0016324 apical plasma membrane | IEA GO_REF:0000120 | ACCEPT | Summary: Computational annotation of apical plasma membrane localization is supported by experimental evidence in retinal pigment epithelial cells. PMID:25983245 showed DRAM2 localizes to the apical surface of RPE cells. Reason: Accurate IEA annotation supported by immunohistochemical evidence showing DRAM2 at the apical surface of RPE cells. This localization is relevant to DRAM2's role in photoreceptor outer segment phagocytosis and renewal. Supporting Evidence: PMID:25983245 Immunohistochemical analysis showed DRAM2 localization to photoreceptor inner segments and to the apical surface of retinal pigment epithelial cells |
| GO:0045494 photoreceptor cell maintenance | IEA GO_REF:0000107 | ACCEPT | Summary: Ensembl Compara orthology-based transfer of photoreceptor cell maintenance annotation is correct. DRAM2 mutations cause CORD21, demonstrating essential role in photoreceptor survival. This duplicates the IBA annotation with the same GO term. Reason: Accurate IEA annotation consistent with human genetic evidence (CORD21) and experimental studies. Duplicate of IBA annotation for same term is acceptable - different evidence tracks support the same annotation. Supporting Evidence: PMID:25983245 DRAM2 encodes a transmembrane lysosomal protein thought to play a role in the initiation of autophagy... involved in the process of photoreceptor renewal and recycling to preserve visual function |
| GO:0005794 Golgi apparatus | IDA GO_REF:0000052 | KEEP AS NON CORE | Summary: HPA immunofluorescence-based annotation suggests Golgi apparatus localization. Recent detailed localization studies in human retinal organoids show DRAM2 proximity to cis-Golgi (GM130) consistent with trafficking through the Golgi during biosynthesis and its role in adaptor-mediated vesicular trafficking [Tsikandelova 2024]. However, the primary functional localization is lysosomal. Reason: Golgi localization likely reflects trafficking during biosynthesis or transient association during vesicular transport. The primary functional localization is the lysosomal membrane. Marking as non-core since this represents a secondary localization. Supporting Evidence: PMID:19895784 DRAM2 is mainly localized in the lysosome file:human/DRAM2/DRAM2-deep-research-falcon.md DRAM2 shows proximity to cis-Golgi (GM130) and mitochondria (TOMM20), consistent with roles at organelle contact/trafficking interfaces |
| GO:0016324 apical plasma membrane | ISS GO_REF:0000024 | ACCEPT | Summary: Sequence similarity-based annotation of apical plasma membrane localization is supported by direct experimental evidence in human tissue. PMID:25983245 demonstrated DRAM2 at the apical surface of RPE cells by immunohistochemistry. This duplicates the IEA annotation for the same term. Reason: Accurate ISS annotation supported by direct experimental evidence in human retinal tissue. Duplicate entries with different evidence codes are acceptable. Supporting Evidence: PMID:25983245 Immunohistochemical analysis showed DRAM2 localization to photoreceptor inner segments and to the apical surface of retinal pigment epithelial cells |
| GO:0045494 photoreceptor cell maintenance | IMP PMID:25983245 Biallelic mutations in the autophagy regulator DRAM2 cause r... | ACCEPT | Summary: Direct experimental evidence from human genetic studies. Biallelic mutations in DRAM2 cause CORD21, characterized by progressive photoreceptor degeneration with early macular involvement. This provides inferred from mutant phenotype evidence that DRAM2 is required for photoreceptor cell maintenance. Reason: Core function of DRAM2 in retina. Strong IMP evidence from multiple independent families showing that DRAM2 loss-of-function mutations cause photoreceptor degeneration. Supporting Evidence: PMID:25983245 Biallelic mutations in the autophagy regulator DRAM2 cause retinal dystrophy with early macular involvement... five families affected by an adult-onset retinal dystrophy with early macular involvement and associated central visual loss in the third or fourth decade of life. Affected individuals were found to harbor disease-causing variants in DRAM2 |
| GO:0001917 photoreceptor inner segment | ISS GO_REF:0000024 | ACCEPT | Summary: Sequence similarity-based annotation of photoreceptor inner segment localization is directly supported by experimental evidence in human tissue. PMID:25983245 demonstrated DRAM2 in photoreceptor inner segments by immunohistochemistry. Reason: Accurate ISS annotation supported by direct experimental evidence in human retinal tissue. Supporting Evidence: PMID:25983245 Immunohistochemical analysis showed DRAM2 localization to photoreceptor inner segments |
| GO:0007601 visual perception | IMP PMID:25983245 Biallelic mutations in the autophagy regulator DRAM2 cause r... | KEEP AS NON CORE | Summary: Human genetic evidence demonstrates DRAM2 is required for visual perception. Patients with biallelic DRAM2 mutations develop visual loss in the third or fourth decade of life with progressive deterioration. This is a downstream consequence of DRAM2's role in photoreceptor maintenance rather than a direct molecular function. Reason: Visual perception loss is a phenotypic consequence of DRAM2 deficiency rather than a direct cellular function. The proximate role is in photoreceptor/RPE cell maintenance via autophagy and lysosomal function; visual perception is the organismal outcome. Marking as non-core but retaining as it accurately reflects the human disease phenotype. Supporting Evidence: PMID:25983245 five families affected by an adult-onset retinal dystrophy with early macular involvement and associated central visual loss in the third or fourth decade of life |
| GO:0010506 regulation of autophagy | IDA PMID:19895784 Reduced expression of DRAM2/TMEM77 in tumor cells interferes... | ACCEPT | Summary: Direct experimental evidence demonstrates DRAM2 involvement in autophagy regulation. While the initial study (PMID:19895784) found DRAM2 overexpression alone did not modulate autophagy (unlike DRAM1), subsequent studies with patient-derived cells show DRAM2 loss impairs autophagic flux (LC3 lipidation defects) [Tsikandelova 2024]. DRAM2 functions in autophagy regulation through a different mechanism than DRAM1. Reason: Core function supported by protein family membership and loss-of-function studies. While overexpression studies were initially negative, patient cell studies clearly demonstrate DRAM2 is required for normal autophagic flux. The IDA annotation reflects DRAM2's involvement in autophagy regulation pathways. Supporting Evidence: PMID:19895784 Damage-regulated autophagy regulator (DRAM) has been identified as an effector molecule that is critical for p53-mediated apoptosis, and we investigated whether there might be other DRAM-like molecules linking autophagy and apoptosis file:human/DRAM2/DRAM2-deep-research-falcon.md DRAM2 deficiency led to impaired autophagic flux (blunted LC3-II changes with bafilomycin/rapamycin) |
| GO:0005737 cytoplasm | IDA PMID:19895784 Reduced expression of DRAM2/TMEM77 in tumor cells interferes... | MARK AS OVER ANNOTATED | Summary: Cytoplasmic localization is a very broad term. While technically accurate (the lysosome is in the cytoplasm), this annotation provides limited information given the more specific lysosomal membrane localization that is well-established. DRAM2 is primarily a membrane protein of lysosomes. Reason: Cytoplasm is too general and uninformative given the specific lysosomal membrane localization. DRAM2 is an integral membrane protein of lysosomes; annotating to 'cytoplasm' adds no meaningful information and may obscure the specific localization. Supporting Evidence: PMID:19895784 DRAM2 is mainly localized in the lysosome |
| GO:0005764 lysosome | IDA PMID:19556885 Analysis of DRAM-related proteins reveals evolutionarily con... | ACCEPT | Summary: Direct experimental evidence from O'Prey et al. demonstrating DRAM2 lysosomal localization. The study showed DRAM2 is a lysosomal protein through immunofluorescence analysis. Reason: Core localization supported by direct experimental evidence. DRAM2 was shown to be a lysosomal protein in this study characterizing DRAM family members. Supporting Evidence: PMID:19556885 DRAM2 is also a lysosomal protein |
| GO:0005764 lysosome | IDA PMID:19895784 Reduced expression of DRAM2/TMEM77 in tumor cells interferes... | ACCEPT | Summary: Direct experimental evidence from Park et al. demonstrating DRAM2 lysosomal localization. The study showed DRAM2 is mainly localized in the lysosome and co-localizes with DRAM1. Reason: Core localization supported by direct experimental evidence through immunofluorescence showing lysosomal localization and co-localization with DRAM1. Supporting Evidence: PMID:19895784 DRAM2 is mainly localized in the lysosome, and co-localizes with DRAM |
Loading supporting content…
Download this section (compressed HTML)Q: What is the precise biochemical mechanism by which DRAM2 regulates autophagic flux? Does it directly scaffold LC3 lipidation machinery or primarily modulate adaptor-coat recruitment?
Q: What are the specific protein-protein interactions of DRAM2 with AP-1/AP-3 adaptor complexes?
Q: What is the functional significance of the different DRAM2 isoforms (DRAM2a vs DRAM2c) in human retina?
Q: Why do photoreceptors and RPE show particular vulnerability to DRAM2 loss compared to other cell types?
Experiment: Proximity ligation assays (PLA) or BioID/TurboID proximity labeling to map DRAM2 interactors at the lysosomal membrane
Hypothesis: DRAM2 directly interacts with AP-1/AP-3 adaptor complexes and/or autophagy machinery components at the lysosomal membrane
Experiment: CRISPR-based functional screens in human retinal organoids to identify genetic modifiers of DRAM2-related phenotypes
Hypothesis: Genes involved in lysosomal biogenesis, autophagy, or lipid metabolism will modify DRAM2-deficient phenotypes
Experiment: Live imaging studies with fluorescent DRAM2 to track its dynamics during autophagy induction and lysosomal biogenesis
Hypothesis: DRAM2 shows dynamic trafficking between Golgi and lysosomes during autophagy induction
Loading supporting content…
Download this section (compressed HTML)Loading supporting content…
Download this section (compressed HTML)